4//SEC Filing
LOSCALZO JOSEPH 4
Accession 0000874015-23-000177
CIK 0000874015other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 6:06 PM ET
Size
10.9 KB
Accession
0000874015-23-000177
Insider Transaction Report
Form 4
LOSCALZO JOSEPH
Director
Transactions
- Exercise/Conversion
Common Stock
2023-07-17+5,333→ 41,082 total - Exercise/Conversion
Restricted Stock Unit
2023-07-17−5,333→ 4,677 totalExercise: $0.00→ Common Stock (5,333 underlying) - Exercise/Conversion
Common Stock
2023-07-17+1,777→ 35,749 total - Exercise/Conversion
Restricted Stock Unit
2023-07-17−1,777→ 10,010 totalExercise: $0.00→ Common Stock (1,777 underlying)
Footnotes (4)
- [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F3]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- [F4]Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001276128
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 6:06 PM ET
- Size
- 10.9 KB